AI-generated summary
The authors studied near-infrared light therapy in astrocytes from Alexander disease patients and in a mouse model of the disease. They report that exposure to 1070 nm light regulated AMPK/mTOR signaling, promoted mitophagy, and reduced reactive oxygen species and inflammation. The authors suggest the approach may be a non-invasive option worth further study.
- Who or what was studied
- Astrocytes derived from Alexander disease patients and a mouse model of Alexander disease
- Wavelengths
- 1070 nm
- Limits stated in the abstract
- The abstract describes cell and animal experiments only, with no human clinical outcomes reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Reactive oxygen species, Inflammation, Mitochondria. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.